Page last updated: 2024-09-04

atazanavir sulfate and Hypertriglyceridemia

atazanavir sulfate has been researched along with Hypertriglyceridemia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Behrens, GM; Castro-Frenzel, B; Christensen, S; Esser, S; Fätkenheuer, G; Lubach-Ruitman, M; Möbius, U; Rump, JA; Schmidt, RE; Stoll, M; Voigt, E	1
Aouadi, M; Binétruy, B; Cardot-Leccia, N; Dellamonica, P; Durant, J; Garraffo, R; Heripret, L; Lavrut, T; Le Marchand-Brustel, Y; Perrin, C; Prot, M	1

Trials

1 trial(s) available for atazanavir sulfate and Hypertriglyceridemia

Article	Year
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia. Journal of acquired immune deficiency syndromes (1999), 2005, Jun-01, Volume: 39, Issue:2 Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oligopeptides; Pyridines; Triglycerides	2005

Article

Year

Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.

Journal of acquired immune deficiency syndromes (1999), 2005, Jun-01, Volume: 39, Issue:2

Topics: Adolescent; Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cholesterol; Cohort Studies; Female; HIV Infections; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; Male; Middle Aged; Oligopeptides; Pyridines; Triglycerides

2005

Other Studies

1 other study(ies) available for atazanavir sulfate and Hypertriglyceridemia

Article	Year
Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12 Topics: Adipose Tissue; Animals; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; HIV Protease Inhibitors; Hypertriglyceridemia; Lopinavir; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pyridines; Pyrimidinones; Ritonavir; RNA, Messenger; Time Factors; Triglycerides	2006

Article

Year

Long-term treatment with lopinavir-ritonavir induces a reduction in peripheral adipose depots in mice.

Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

Topics: Adipose Tissue; Animals; Atazanavir Sulfate; Dose-Response Relationship, Drug; Drug Interactions; HIV Protease Inhibitors; Hypertriglyceridemia; Lopinavir; Male; Mice; Mice, Inbred C57BL; Oligopeptides; Pyridines; Pyrimidinones; Ritonavir; RNA, Messenger; Time Factors; Triglycerides

2006